HSD17B1 and prostate carcinoma: While previous studies have evaluated whether germline variation in HSD17B1 is associated with breast or endometrial cancer [33–36], this is the first large prospective study to assess HSD17B1 in relation to prostate cancer among men from several ethnicities.